✦ LIBER ✦

Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine

✍ Scribed by Christophe Fraser; Joanne E. Tomassini; Liwen Xi; Greg Golm; Michael Watson; Anna R. Giuliano; Eliav Barr; Kevin A. Ault

Book ID: 116959668
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 561 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.02.069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chimeric Virus-like Particles of the Hum

Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine

✍ Ingrid Jochmus; Klaus Schäfer; Stefan Faath; Martin Müller; Lutz Gissmann 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Induction of immune memory following adm

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

✍ Sven-Eric Olsson; Luisa L. Villa; Ronaldo L.R. Costa; Carlos A. Petta; Rosires P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Mucosal Vaccination with a Recombinant S

Mucosal Vaccination with a Recombinant Salmonella typhimurium Expressing Human Papillomavirus Type 16 (HPV16) L1 Virus-like Particles (VLPs) or HPV16 VLPs Purified from Insect Cells Inhibits the Growth of HPV16-Expressing Tumor Cells in Mice

✍ Véronique Revaz; Jalil Benyacoub; W.Martin Kast; John T Schiller; Pierre De Gran 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Early assessment of the efficacy of a hu

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

✍ Darron R Brown; Kenneth H Fife; Cosette M Wheeler; Laura A Koutsky; Lisa M Lupin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

PS10 Late breaking Prophylactic use of q

PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) risk

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Immunoglobulin-A and -G responses agains

Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions

✍ Toshiyuki Sasagawa; Hiroshi Yamazaki; Yu-Zhen Dong; Shin-ichirou Satake; Masaya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

## Immunoglobulin -A and -G (IgA and IgG) responses against HPV-16-like particles (VLP) were tested by ELISA in 104 women with cervical abnormalities, 26 atypical cells of undetermined significance (ASCUS) and 14 cytologically normal women with HPV DNA. As controls, 130 age-matched cytologically n